Alpa Laboratories Limited (NSE:ALPA)
66.97
-0.68 (-1.01%)
Feb 16, 2026, 3:28 PM IST
Alpa Laboratories Market Cap
Alpa Laboratories has a market cap or net worth of 1.42 billion as of February 13, 2026. Its market cap has decreased by -39.96% in one year.
Market Cap
1.42B
Enterprise Value
33.58M
Revenue
1.14B
Ranking
n/a
PE Ratio
12.26
Stock Price
66.97
Market Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has increased from 1.15B to 1.42B, an increase of 23.45%. That is a compound annual growth rate of 1.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.42B | -12.92% |
| Dec 31, 2025 | 1.63B | -34.42% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 11.10B |
| Sakar Healthcare | 9.94B |
| Sigachi Industries | 8.79B |
| Valiant Laboratories | 3.33B |
| Bafna Pharmaceuticals | 2.93B |
| Nectar Lifesciences | 2.60B |
| Brooks Laboratories | 2.23B |
| Par Drugs and Chemicals | 1.19B |